MILLER STRATEGIES, LLC

Lobbying for ALZHEON, INC. · Biopharmaceutical

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · $180,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

Health Issues

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.